Tenon Medical (TNON) director converts 10,147 RSUs to common stock
Rhea-AI Filing Summary
Tenon Medical director Kristine M Jacques converted 10,147 restricted stock units, granted on October 13, 2025, into 10,147 shares of common stock on July 31, 2026. Following this RSU conversion, she directly holds 20,876 shares of Tenon Medical common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,147 shares
Net Buy
2 txns
Insider
Jacques Kristine M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 10,147 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 10,147 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 20,876 shares (Direct)
Footnotes (2)
- F1. Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026.
- F2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Key Figures
RSUs converted: 10,147 units
Common shares acquired: 10,147 shares
Shares held after transaction: 20,876 shares
+1 more
4 metrics
RSUs converted
10,147 units
Restricted stock units converted to common stock on July 31, 2026
Common shares acquired
10,147 shares
Shares of common stock received from RSU conversion on July 31, 2026
Shares held after transaction
20,876 shares
Director's direct Tenon Medical common stock holdings following the RSU conversion
Stated transaction price
0.0000 per share
Price field for the RSU conversion transaction
Key Terms
Restricted Stock Units, derivative security, contingent right
3 terms
Restricted Stock Units financial
"Represents conversion of 10,147 restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction code description "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Tenon Medical (TNON) report for Kristine M Jacques?
Tenon Medical reported that director Kristine M Jacques converted 10,147 restricted stock units into 10,147 shares of common stock on July 31, 2026, increasing her direct holdings to 20,876 shares of Tenon Medical common stock.
What was converted in the July 31, 2026 Tenon Medical (TNON) insider transaction?
On July 31, 2026, 10,147 restricted stock units held by director Kristine M Jacques were converted into 10,147 shares of Tenon Medical common stock. Each restricted stock unit represented a contingent right to receive one share of common stock.
Did the Tenon Medical (TNON) director buy or sell stock in this Form 4 filing?
The filing shows a conversion of restricted stock units into common stock, not an open-market buy or sell. The RSUs were disposed as derivatives and the same 10,147 shares of common stock were acquired directly by the director.
When were the restricted stock units granted that Tenon Medical (TNON) reported as converted?
The 10,147 restricted stock units converted on July 31, 2026 were originally granted to director Kristine M Jacques on October 13, 2025, according to the Form 4 footnote disclosure from Tenon Medical.